- Home
- ADCT vs NFBK Comparison
ADCT vs NFBK Comparison
Compare ADCT & NFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- NFBK
- Stock Information
- Founded
- ADCT 2011
- NFBK 1887
- Country
- ADCT Switzerland
- NFBK United States
- Employees
- ADCT N/A
- NFBK N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- NFBK Major Banks
- Sector
- ADCT Health Care
- NFBK Finance
- Exchange
- ADCT Nasdaq
- NFBK Nasdaq
- Market Cap
- ADCT 380.2M
- NFBK 454.5M
- IPO Year
- ADCT 2020
- NFBK 2007
- Fundamental
- Price
- ADCT $4.46
- NFBK $10.22
- Analyst Decision
- ADCT Strong Buy
- NFBK Hold
- Analyst Count
- ADCT 6
- NFBK 3
- Target Price
- ADCT $7.60
- NFBK $12.67
- AVG Volume (30 Days)
- ADCT 984.4K
- NFBK 197.2K
- Earning Date
- ADCT 11-07-2025
- NFBK 10-22-2025
- Dividend Yield
- ADCT N/A
- NFBK 5.09%
- EPS Growth
- ADCT N/A
- NFBK 51.92
- EPS
- ADCT N/A
- NFBK 0.97
- Revenue
- ADCT $77,246,000.00
- NFBK $141,983,000.00
- Revenue This Year
- ADCT $11.78
- NFBK $8.04
- Revenue Next Year
- ADCT $4.83
- NFBK $17.33
- P/E Ratio
- ADCT N/A
- NFBK $10.51
- Revenue Growth
- ADCT 15.73
- NFBK 13.99
- 52 Week Low
- ADCT $1.05
- NFBK $9.40
- 52 Week High
- ADCT $4.80
- NFBK $14.39
- Technical
- Relative Strength Index (RSI)
- ADCT 59.09
- NFBK 34.67
- Support Level
- ADCT $3.92
- NFBK $10.61
- Resistance Level
- ADCT $4.80
- NFBK $11.24
- Average True Range (ATR)
- ADCT 0.25
- NFBK 0.36
- MACD
- ADCT 0.00
- NFBK -0.07
- Stochastic Oscillator
- ADCT 61.36
- NFBK 7.30
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About NFBK Northfield Bancorp Inc. (Delaware)
Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.